CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-20 | Wysenski Nancy Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | Wysenski Nancy Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | Wilson Frank Anders Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | Wilson Frank Anders Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | snyderman nancy lynn MD Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | snyderman nancy lynn MD Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | MITCHELL PAUL J Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | MITCHELL PAUL J Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | GAYNOR RICHARD Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | GAYNOR RICHARD Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | DIXON WENDY L Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | DIXON WENDY L Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | Cooke Shane Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | BREYER ROBERT A Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | BREYER ROBERT A Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-20 | ANSTICE DAVID W Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +12,823 | 12,823 | ||
| 2020-05-20 | ANSTICE DAVID W Director | Grant or award · Restricted Stock Unit Award | +6,104 | 6,104 | ||
| 2020-05-14 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion | +75,000 | $11.74 | $881K | 834,094 |
| 2020-05-14 | POPS RICHARD F Director and CEO, Alkermes plc | Sale | −75,000 | $15.00 | $1.1M | 759,094 |
Page 72 of 75 · 1,492 trades